EPENDYMOMA
Clinical trials for EPENDYMOMA explained in plain language.
Never miss a new study
Get alerted when new EPENDYMOMA trials appear
Sign up with your email to follow new studies for EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lab test could match brain tumor patients to the right drug
Disease control Not yet recruitingThis study tests a new approach called pharmacoscopy, which uses a lab test on a patient's tumor sample to find which drugs might work best for them. It involves 40 adults with brain tumors like glioblastoma that have not responded to standard treatments. The goal is to see if th…
Matched conditions: EPENDYMOMA
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated May 26, 2026 11:28 UTC
-
New proton therapy spares spine growth in kids with brain cancer
Disease control Not yet recruitingThis study looks at a new way to give radiation to children with brain tumors that need whole-brain and whole-spine treatment. The technique, called vertebral body-sparing proton therapy, aims to protect the front of the spine bones to preserve bone marrow and growth. Researchers…
Matched conditions: EPENDYMOMA
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 11:27 UTC
-
Immune cells engineered to hunt brain tumors: new trial opens for kids
Disease control Not yet recruitingThis early-phase trial tests a new cell therapy called B7-H3 CAR T cells for children and young adults whose brain tumors have come back or are growing despite standard treatment. The therapy uses a patient's own immune cells, modified to recognize and attack a protein (B7-H3) fo…
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated May 26, 2026 11:21 UTC
-
New combo therapy targets deadly childhood brain cancers
Disease control Not yet recruitingThis study tests a combination of a vaccine (PEP-CMV) and an immunotherapy drug (nivolumab) in children and young adults with certain aggressive brain tumors. The goal is to see if this approach is safe and helps the immune system fight the cancer. About 68 participants will be e…
Matched conditions: EPENDYMOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC